Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 21 EP applications Thomas Winkler has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 25, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12735395

ANTI-C-MET ANTIBODY FORMULATIONS

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP12748808

METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS

IPC classification:
A61K 39/395, C07K 16/30, C07K 16/28, A61P 35/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP12768982

COMBINATION TREATMENTS COMPRISING C-MET ANTAGONISTS AND B-RAF ANTAGONISTS

IPC classification:
A61K 45/06, A61K 39/395, A61K 31/4439, A61K 31/437
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12778020

ZYMOGEN ACTIVATORS

IPC classification:
A61K 38/18, C07K 14/475, C07K 7/06
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP12794841

PURIFICATION OF ANTI-C-MET ANTIBODIES

IPC classification:
C07K 16/28, C07K 16/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13791411

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR

IPC classification:
A61K 39/395
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13736741

EXPRESSION AND SECRETION SYSTEM

IPC classification:
C12N 15/76, C12N 15/74, C12N 15/64
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14757519

METHODS OF MODULATING DLK STABILITY

IPC classification:
A61P 25/28, A61K 31/7105, A61K 39/395
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP14756179

COMPOSITIONS AND METHOD FOR TREATING COMPLEMENT-ASSOCIATED CONDITIONS

IPC classification:
C12Q 1/68
Applicant:
Genentech, Inc.
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14827379

ANTIBODIES AND METHODS OF USE

IPC classification:
C07K 16/46, C07K 16/28, C07K 16/18, C07K 14/71, A61K 39/395
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15716253

CANCER TREATMENT WITH C-MET ANTAGONISTS AND CORRELATION OF THE LATTER WITH HGF EXPRESSION

IPC classification:
C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15721516

ANTI-FACTOR D ANTIBODY VARIANTS AND USES THEREOF

IPC classification:
C12N 9/64, C07K 16/40
Applicant:
Genentech, Inc.
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP16193134

PREDICTING PROGRESSION TO ADVANCED AGE-RELATED MACULAR DEGENERATION USING A POLYGENIC SCORE

IPC classification:
G06F 19/18, C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15742329

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

IPC classification:
C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP16193195

LOW AFFINITY ANTI TRANSFERRIN RECEPTOR AND THEIR USE TO TRANSFER THERAPEUTIC SCFV ACROSS THE BLOOD BRAIN BARRIER

IPC classification:
A61K 39/395, C07K 16/46, C07K 16/18, C07K 16/40, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
The application has been published
EP17160544

FGFR1 AGONISTS AND METHODS OF USE

IPC classification:
A61K 39/395, A61P 3/10, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
The application has been published
EP17174320

TYPE II ANTI-CD20 ANTIBODY AND ANTI-CD20/CD3 BISPECIFIC ANTIBODY FOR TREATMENT OF CANCER

IPC classification:
C07K 16/30, A61K 39/395, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
The application has been published
EP16725982

COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS

IPC classification:
C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16725104

COMBINATION THERAPY OF AN ANTI CD20 ANTIBODY WITH A BCL-2 INHIBITOR AND A MDM2 INHIBITOR

IPC classification:
C07K 16/28, A61P 35/02, A61K 31/40, A61K 31/496, A61K 39/395
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16739327

TYPE II ANTI-CD20 ANTIBODY FOR USE IN ORGAN TRANSPLANTATION

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16733812

HUMANIZED AND AFFINITY MATURED ANTIBODIES TO FCRH5 AND METHODS OF USE

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
Request for examination was made

Please Sign in to use this feature